Does GONADORELIN Cause Malignant neoplasm progression? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Malignant neoplasm progression have been filed in association with GONADORELIN. This represents 8.9% of all adverse event reports for GONADORELIN.
20
Reports of Malignant neoplasm progression with GONADORELIN
8.9%
of all GONADORELIN reports
0
Deaths
4
Hospitalizations
How Dangerous Is Malignant neoplasm progression From GONADORELIN?
Of the 20 reports, 4 (20.0%) required hospitalization, and 7 (35.0%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GONADORELIN. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does GONADORELIN Cause?
Ovarian hyperstimulation syndrome (32)
Neutropenia (31)
Metastases to bone (24)
Headache (20)
White blood cell count decreased (20)
Carcinoembryonic antigen increased (15)
Breast cancer (14)
Nausea (14)
Central nervous system lesion (13)
Neutrophil count decreased (13)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which GONADORELIN Alternatives Have Lower Malignant neoplasm progression Risk?
GONADORELIN vs GONADOTROPHIN, CHORIONIC
GONADORELIN vs GOSERELIN
GONADORELIN vs GRAMICIDIN
GONADORELIN vs GRAMICIDIN\NEOMYCIN\POLYMYXIN B
GONADORELIN vs GRAMICIDIN\POLYMYXIN B